Senior Director - Therapy Area Modelling Lead, Pharma
GSK
2 months ago
Remote friendly (Collegeville, PA)
United States
Market Access
In this role, you will lead a team applying innovative modelling/evidence-generation approaches to shape reimbursement and access strategy across therapeutic areas. You will develop transparent, robust cost-effectiveness, public health impact, and budget-impact models, and models for early decision-making.
Responsibilities:
- Lead, build, and mentor an economic modelling team across Pharma therapy areas.
- Lead development of global models for medicines preparing for launch/HTA reimbursement applications.
- Engage external experts/decision-makers, HTA agencies, and policy/methodology forums to drive innovation.
- Facilitate alignment across stakeholders (clinical, commercial, market access, medical affairs priority market LOCs).
- Deliver materials to support internal governance (e.g., Medical Review Board).
- Lead early economic models to inform clinical development, trial design, and evidence plans.
- Serve as an in-house expert on modelling, HTA requirements, and payer evidence needs.
- Represent the modelling function in scientific advice meetings and cross-functional asset/external engagements.
Basic/Required Qualifications & Skills:
- Advanced degree in a relevant health discipline (e.g., Pharmacy, health outcomes research, health economics, economics).
- Significant experience leading economic model development/outcomes research in industry, academia, or research organizations.
- Experience contributing to HTA submissions/reimbursement dossiers.
- Evidence leading partnerships with Commercial, Market Access, and R&D.
- Technical skills with modelling software/programming (e.g., R, Excel, decision-analytic tools).
- Experience managing vendors and ensuring quality of outsourced deliverables.
- Strong written/verbal communication; ability to influence technical and non-technical audiences.
- Proven cross-functional leadership delivering complex projects on time.
Preferred:
- PhD; peer-reviewed publications (lead/first author).
- Cost-effectiveness and budget-impact modelling with local adaptations across major markets.
- Familiarity with real-world evidence (RWE).
- Experience in global pharma/biotech/CRO with exposure to multiple HTA systems.
Application instructions:
- Hybrid role (2–3 days/week in office).
- Closing date: 21 April 2026 (EOD). Apply using your cover letter (or CV) to describe how you meet the competencies.
Responsibilities:
- Lead, build, and mentor an economic modelling team across Pharma therapy areas.
- Lead development of global models for medicines preparing for launch/HTA reimbursement applications.
- Engage external experts/decision-makers, HTA agencies, and policy/methodology forums to drive innovation.
- Facilitate alignment across stakeholders (clinical, commercial, market access, medical affairs priority market LOCs).
- Deliver materials to support internal governance (e.g., Medical Review Board).
- Lead early economic models to inform clinical development, trial design, and evidence plans.
- Serve as an in-house expert on modelling, HTA requirements, and payer evidence needs.
- Represent the modelling function in scientific advice meetings and cross-functional asset/external engagements.
Basic/Required Qualifications & Skills:
- Advanced degree in a relevant health discipline (e.g., Pharmacy, health outcomes research, health economics, economics).
- Significant experience leading economic model development/outcomes research in industry, academia, or research organizations.
- Experience contributing to HTA submissions/reimbursement dossiers.
- Evidence leading partnerships with Commercial, Market Access, and R&D.
- Technical skills with modelling software/programming (e.g., R, Excel, decision-analytic tools).
- Experience managing vendors and ensuring quality of outsourced deliverables.
- Strong written/verbal communication; ability to influence technical and non-technical audiences.
- Proven cross-functional leadership delivering complex projects on time.
Preferred:
- PhD; peer-reviewed publications (lead/first author).
- Cost-effectiveness and budget-impact modelling with local adaptations across major markets.
- Familiarity with real-world evidence (RWE).
- Experience in global pharma/biotech/CRO with exposure to multiple HTA systems.
Application instructions:
- Hybrid role (2–3 days/week in office).
- Closing date: 21 April 2026 (EOD). Apply using your cover letter (or CV) to describe how you meet the competencies.